Press Releases - G1 Therapeutics, Inc.

Press Releases

Date	Title
9/21/18	G1 Therapeutics Announces Closing of Offering of Common Stock
9/18/18	G1 Therapeutics Announces Pricing of Offering of Common Stock
9/17/18	G1 Therapeutics Announces Proposed Offering of Common Stock
9/17/18	G1 Therapeutics to Report Myelopreservation Data from Randomized Phase 2 Trial of Trilaciclib/Chemotherapy/Tecentriq® in Small Cell Lung Cancer in Fourth Quarter 2018
9/13/18	G1 Therapeutics Announces Appointment of Garry Nicholson to Board of Directors
8/28/18	G1 Therapeutics to Present at H.C. Wainwright Investment Conference on September 5, 2018
8/8/18	G1 Therapeutics Provides Second Quarter 2018 Corporate and Financial Update
8/7/18	G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference on August 14, 2018
8/1/18	G1 Therapeutics to Provide Second Quarter 2018 Corporate and Financial Update on August 8, 2018
7/9/18	G1 Therapeutics Expands Executive Leadership Team with Appointment of John Demaree as Chief Commercial Officer and Stillman Hanson as General Counsel